Entity

Daiichi Sankyo

Japanese pharmaceutical company

Express your sentiment! Sign in!
Entity sentiment
1
AstraZeneca"s cancer drug trial results disappoint investors
AstraZeneca Japan Daiichi Sankyo
Promising Results for ifinatamab deruxtecan in Small Cell Lung Cancer Trial
Daiichi Sankyo
You've reached the end